Antitumor effect of IMGN289, an anti-EGFR antibody-drug conjugate (ADC), in preclinical models of head and neck squamous cell carcinomas (HNSCC).
Hyunseok Kang
Research Funding - Immunogen
Manjusha Thakar
No relevant relationships to disclose
Rupashree Sen
No relevant relationships to disclose
Christine H. Chung
Research Funding - Immunogen